Jubilant Pharmova Limited announced that Jubilant HollisterStier LLC (JHS) has received a communication from the USFDA, through which the regulatory agency intimated that pursuant to its audit of JHS's contract manufacturing facility located at Spokane, Washington (USA) from May 28,2024 to June 6, 2024, it has determined the inspection classification of the facility as "Voluntary Action Indicated" (VAI).

Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding, which is a subsidiary of Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of the company.